$25.1 billion) in sales last year, would create a drugmaker on par with European rivals Sanofi-Aventis SA,...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
GLAXOSMITHKLINE PLC
GlaxoSmithKline plc (GSK) is currently the second-largest pharmaceutical company in the world. Its pharmaceutical segment covers anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. The company produces the popular asthma medicine Advair. GSK’s consumer healthcare segment handles products such as oral healthcare, nutritional drinks, and over the counter medicines. Founded in 1935, GSK’s headquarters are located in Uxbridge, UK.
GlaxoSmithKline plc is part of Business Exchange, suggested by
Ulli Muenker.
This topic contains
761 news
and
87 blog
items.
Read updated news, blogs, and resources about GlaxoSmithKline plc. Find user-submitted articles and reactions on GlaxoSmithKline plc from
like-minded professionals.
News
Please add new articles to this topic
Extract not available.
and its LPs have not seen an exit from the company, Epizyme has a $650 million alliance with GlaxoSmithKline PLC, and...
billion euros ($25.1 billion) in sales last year, would create a drugmaker on par with Sanofi-Aventis SA,...
billion euros ($25.1 billion) in sales last year, would create a drugmaker on par with Sanofi-Aventis SA,...
" Simon Gergel, portfolio manager of the 93 million pound Allianz RCM UK Equity Income Fund. Gergel cited...
recently installed a 406 kW peak solar photovoltaic energy system on the roof of the Administrative Center at...
$25.1 billion) in sales last year, would create a drugmaker on par with European rivals Sanofi-Aventis SA,...
$25.1 billion) in sales last year, would create a drugmaker on par with European rivals Sanofi-Aventis SA,...
00 cents 0.86 Barclays (BARC.L) 1.00 0.47 G4S (GFS.L) 4.73 0.26 GlaxoSmithKline (GSK.L) 16.00 3.20 Kingfisher (KGF.L) 5.
getting it from Treasury bonds. The yield on the 10-year U.S. Treasury is a measly 3.27%. GlaxoSmithKline (GSK), Merck...
May 3 (Bloomberg) -- GlaxoSmithKline Plc has paid at least $120 million to resolve claims that some of its Poligrip...
oncology and virology, announced that it has achieved multiple early milestones in its fragment-based drug discovery...
Plc Eisai Co., Ltd Eli Lilly and Company EMPI, INC F. Hoffmann-La Roche Ltd Fujisawa Pharmaceutical Co.
2009 got a $10 million grant from NIDA, and sealed a licensing pact with the U.K.'s GlaxoSmithKline PLC that, including...
triglycerides without boosting LDL. This would differentiate it from the blockbuster prescription fish oil pill Lovaza,...
run as chairman, replacing longstanding Rob Cawthorn. Elliott is also backing Actelion board nominees Jean-Pierre...
the new facility will give impetus to the company's collaborations with global pharma companies, including Pfizer and...
profitability, analysts said. "The competitors who have entered this category are big players such as ITC ,...
NEW DELHI: GlaxoSmithKline Consumer Healthcare Limited (GSKCH), makers of the 'Horlicks' brand of health drinks and...
38 products across Europe, Canada, Australia, New Zealand, Japan and Korea. Strides also has an outlicensing deal with...
many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and various fibrotic diseases.
its ability to launch products worldwide. The company has licensing and supply partnerships with leading MNCs - Pfizer...
and hands-on involvement from the very top at the companies developing a strong bench of future leaders.
Operations Intermountain Healthcare Christopher W. Soong Principal Booz Allen Hamilton Joe Touey SVP of North America...
Top Sources: GlaxoSmithKline plc
- Financial Times
- Morningstar.com
- MarketWatch
- BusinessWeek
- TheStreet.com
- Philadelphia Inquirer
- Reuters UK
- Reuters
- google.com
- New York Times
account